(RGTI) Rigetti Computing - Ratings and Ratios
Quantum Computers, Quantum Processors, QCaaS, QPU, Quantum Software
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 88.5% |
| Value at Risk 5%th | 125% |
| Relative Tail Risk | -14.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.27 |
| Alpha | -8.70 |
| CAGR/Max DD | 2.57 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.548 |
| Beta | 2.567 |
| Beta Downside | 1.868 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.83% |
| Mean DD | 46.70% |
| Median DD | 53.73% |
Description: RGTI Rigetti Computing January 09, 2026
Rigetti Computing, Inc. (NASDAQ:RGTI) designs and manufactures superconducting quantum processors and delivers them via a cloud-based Quantum Computing-as-a-Service (QCaaS) platform. Its product lineup includes the 9-qubit “Novera” QPU, the 84-qubit “Ankaa-3” system, and a suite of quantum-cloud services that support both public and private cloud integrations, quantum operating system software, and professional services such as algorithm development and benchmarking.
The company targets a diversified client base that spans commercial enterprises, U.S. and foreign government agencies, and research institutions. Founded in 2013 and headquartered in Berkeley, California, Rigetti operates globally across the United States, Europe, and Asia.
Recent financial filings (Q3 2024) show approximately $45 million of cash on hand and a year-over-year revenue increase of roughly 35 % to $12 million, reflecting growing demand for quantum-cloud access. The broader quantum-computing market is projected to expand at a ~30 % CAGR, reaching $5 billion by 2030, driven by increased R&D spending and corporate adoption of quantum-enhanced optimization. Rigetti’s partnership with Amazon Web Services to integrate its QPUs into the AWS Braket ecosystem is a key catalyst for scaling user adoption.
For a deeper quantitative view, you might explore ValueRay’s analyst toolkit to evaluate RGTI’s valuation metrics and risk profile.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-351.0m TTM) > 0 and > 6% of Revenue (6% = 449.6k TTM) |
| FCFTA -0.11 (>2.0%) and ΔFCFTA 31.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5934 % (prev 693.0%; Δ 5241 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.08 (>3.0%) and CFO -52.2m > Net Income -351.0m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 39.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (325.0m) change vs 12m ago 72.53% (target <= -2.0% for YES) |
| Gross Margin 32.23% (prev 33.50%; Δ -1.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.90% (prev 7.56%; Δ -5.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -885.6 (EBITDA TTM -387.4m / Interest Expense TTM 446.0k) >= 6 (WARN >= 3) |
Altman Z'' -9.06
| (A) 0.71 = (Total Current Assets 456.3m - Total Current Liabilities 11.6m) / Total Assets 630.3m |
| (B) -1.19 = Retained Earnings (Balance) -752.8m / Total Assets 630.3m |
| warn (B) unusual magnitude: -1.19 — check mapping/units |
| (C) -1.00 = EBIT TTM -395.0m / Avg Total Assets 393.8m |
| (D) -2.91 = Book Value of Equity -752.0m / Total Liabilities 258.4m |
| Total Rating: -9.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.93
| 1. Piotroski 0.0pt |
| 2. FCF Yield -0.86% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.02 |
| 5. Debt/Ebitda 0.05 |
| 7. RoE -111.5% |
| 8. Rev. Trend -7.96% |
| 9. EPS Trend 29.17% |
What is the price of RGTI shares?
Over the past week, the price has changed by +4.75%, over one month by -12.40%, over three months by -47.53% and over the past year by +176.82%.
Is RGTI a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RGTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.2 | 54.7% |
| Analysts Target Price | 38.2 | 54.7% |
| ValueRay Target Price | 27.9 | 12.7% |
RGTI Fundamental Data Overview January 10, 2026
P/B = 22.3759
Beta = 1.713
Revenue TTM = 7.49m USD
EBIT TTM = -395.0m USD
EBITDA TTM = -387.4m USD
Long Term Debt = 7.60m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.22m USD (from shortTermDebt, last quarter)
Debt = 7.60m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -18.5m USD (from netDebt column, last quarter)
Enterprise Value = 7.89b USD (8.33b + Debt 7.60m - CCE 447.0m)
Interest Coverage Ratio = -885.6 (Ebit TTM -395.0m / Interest Expense TTM 446.0k)
EV/FCF = -116.8x (Enterprise Value 7.89b / FCF TTM -67.6m)
FCF Yield = -0.86% (FCF TTM -67.6m / Enterprise Value 7.89b)
FCF Margin = -901.7% (FCF TTM -67.6m / Revenue TTM 7.49m)
Net Margin = -4683 % (Net Income TTM -351.0m / Revenue TTM 7.49m)
Gross Margin = 32.23% ((Revenue TTM 7.49m - Cost of Revenue TTM 5.08m) / Revenue TTM)
Gross Margin QoQ = 20.75% (prev 31.43%)
Tobins Q-Ratio = 12.52 (Enterprise Value 7.89b / Total Assets 630.3m)
Interest Expense / Debt = 5.87% (Interest Expense 446.0k / Debt 7.60m)
Taxrate = -0.0% (0.0 / -201.0m)
NOPAT = -395.0m (EBIT -395.0m * (1 - -0.00%)) [loss with tax shield]
Current Ratio = 39.22 (Total Current Assets 456.3m / Total Current Liabilities 11.6m)
Debt / Equity = 0.02 (Debt 7.60m / totalStockholderEquity, last quarter 371.8m)
Debt / EBITDA = 0.05 (negative EBITDA) (Net Debt -18.5m / EBITDA -387.4m)
Debt / FCF = 0.27 (negative FCF - burning cash) (Net Debt -18.5m / FCF TTM -67.6m)
Total Stockholder Equity = 314.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -89.13% (Net Income -351.0m / Total Assets 630.3m)
RoE = -111.5% (Net Income TTM -351.0m / Total Stockholder Equity 314.7m)
RoCE = -122.6% (out of range, set to none) (EBIT -395.0m / Capital Employed (Equity 314.7m + L.T.Debt 7.60m))
RoIC = -125.5% (out of range, set to none) (NOPAT -395.0m / Invested Capital 314.7m)
WACC = 15.37% (E(8.33b)/V(8.34b) * Re(15.38%) + D(7.60m)/V(8.34b) * Rd(5.87%) * (1-Tc(-0.0)))
Discount Rate = 15.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 52.08%
Fair Price DCF = unknown (Cash Flow -67.6m)
EPS Correlation: 29.17 | EPS CAGR: 18.70% | SUE: 0.15 | # QB: 0
Revenue Correlation: -7.96 | Revenue CAGR: 9.68% | SUE: -0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.03 | Chg30d=+0.003 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=-0.14 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=+1.4% | Growth Revenue=+169.4%
Additional Sources for RGTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle